Management of node-positive melanoma in the era of sentinel node biopsy

Rebekah R. White, Douglas S. Tyler

Research output: Contribution to journalArticle

8 Scopus citations


Regional lymph node metastasis is a powerful predictor of decreased overall survival from malignant melanoma. However, the therapeutic value of elective node dissections and the role of adjuvant therapy for node-positive disease have been highly controversial. Sentinel lymph node biopsy has reshaped the debate by allowing for staging of the regional lymph nodes with less morbidity and greater accuracy. This review summarizes the current consensus on the management of node-positive melanoma in the era of sentinel lymph node biopsy.

Original languageEnglish (US)
Pages (from-to)119-125
Number of pages7
JournalSurgical oncology
Issue number3
StatePublished - Nov 1 2000
Externally publishedYes



  • Adjuvant therapy
  • Lymph node dissection
  • Lymph node metastasis
  • Melanoma
  • Sentinel lymph node biopsy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this